Oncternal Therapeutics Inc. (ONCT) to Voluntarily Delist from Nasdaq and Deregister with the SEC Mar 7, 2025 04:06PM
Oncternal Therapeutics Inc. (ONCT) Reports Updated Safety and Efficacy Data for Phase 1/2 Study of ONCT-534 Oct 22, 2024 09:01AM
Northland Downgrades Oncternal Therapeutics (ONCT) to Market Perform Sep 12, 2024 01:42PM
Oncternal Therapeutics (ONCT) Announces Termination of its Clinical Studies and Exploration of Strategic Alternatives Sep 12, 2024 09:01AM